Brooklyn FI LLC Makes New $441,000 Investment in Oscar Health, Inc. (NYSE:OSCR)

Brooklyn FI LLC acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, Holdings Channel.com reports. The firm acquired 32,832 shares of the company’s stock, valued at approximately $441,000.

Several other institutional investors and hedge funds also recently made changes to their positions in OSCR. State Street Corp lifted its stake in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after buying an additional 291,335 shares during the period. Geode Capital Management LLC increased its stake in shares of Oscar Health by 11.7% in the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after acquiring an additional 455,205 shares in the last quarter. Hennessy Advisors Inc. lifted its position in shares of Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after acquiring an additional 3,544,300 shares during the period. JPMorgan Chase & Co. boosted its stake in Oscar Health by 68.5% during the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after acquiring an additional 938,742 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in Oscar Health by 3.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,654,862 shares of the company’s stock worth $22,241,000 after purchasing an additional 54,696 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Up 0.0 %

OSCR opened at $12.84 on Thursday. The firm has a market capitalization of $3.22 billion, a PE ratio of -641.43 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a fifty-two week low of $12.43 and a fifty-two week high of $23.79. The company’s 50-day moving average is $15.11 and its 200 day moving average is $16.28.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

OSCR has been the topic of several research reports. Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Wells Fargo & Company downgraded Oscar Health from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Oscar Health presently has an average rating of “Hold” and a consensus target price of $20.19.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.